Nexvet Biopharma plc 4
4 · Nexvet Biopharma plc · Filed Jul 5, 2017
Insider Transaction Report
Form 4
Farrell Geraldine T
VP Operations, General Counsel
Transactions
- Exercise/Conversion
Option to Purchase Shares
2017-07-01−2,866→ 0 total(indirect: By Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C>)Exercise: $0.13From: 2017-07-01Exp: 2019-07-01→ Ordinary Shares (2,866 underlying) - Exercise/Conversion
Ordinary Shares
2017-07-01$0.13/sh+10,000$1,250→ 16,640 total - Exercise/Conversion
Ordinary Shares
2017-07-01$0.13/sh+2,340$293→ 18,980 total - Exercise/Conversion
Ordinary Shares
2017-07-01$0.13/sh+6,194$774→ 33,180 total(indirect: Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C>) - Exercise/Conversion
Restricted Share Units
2017-07-01−10,000→ 30,000 totalExercise: $0.13From: 2017-07-01Exp: 2021-07-01→ Ordinary Shares (10,000 underlying) - Exercise/Conversion
Ordinary Shares
2017-07-01$0.13/sh+2,866$358→ 26,986 total(indirect: By Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C>) - Exercise/Conversion
Restricted Share Units
2017-07-01−2,340→ 4,678 totalExercise: $0.13From: 2017-07-01Exp: 2020-07-01→ Ordinary Shares (2,340 underlying) - Exercise/Conversion
Option to Purchase Shares
2017-07-01−6,194→ 0 total(indirect: Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C>)Exercise: $0.13From: 2016-11-05Exp: 2023-11-05→ Ordinary Shares (6,194 underlying)
Footnotes (3)
- [F1]The reporting person and her spouse have shared voting and dispositive power with respect to these reported securities.
- [F2]10,000 of the Restricted Share Units vested and became convertible on 7/1/17 and 10,000 of the Restricted Share Units shall vest and become convertible on each of 7/1/18, 7/1/19 and 7/1/20, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting.
- [F3]2,340 of the Restricted Share Units vested and became convertible on 7/1/17 and 2,339 of the Restricted Share Units shall vest and become convertible on each of 7/1/18 and 7/1/19, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting.